Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000038094Phase 4Not yet recruiting
Phase 4, randomised, single-blind trial of remimazolam and propofol in general anesthesia (4 arms), sponsored by Suining Central Hospital. Primary endpoints: Consciousness vanishing time and Withdrawal time. Planned start Aug 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000038094.